Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCG
4851
CALL
DELISTED
Scana
SCG
| $115K | ﹤0.01% |
+2,400
| New | +$103K |
|
|
ANSS
4852
CALL
DELISTED
Ansys
ANSS
| $114K | ﹤0.01% |
800
-2,200
| -73% | -$342K |
|
4853
CALL
Ashland
ASH
$3.43B
| $114K | ﹤0.01% |
1,600
+1,100
| +220% | +$84.8K |
|
4854
ProShares UltraShort Gold
GLL
$102M
| $114K | ﹤0.01% |
+393
| New | +$124K |
|
|
NGD
4855
CALL
DELISTED
New Gold Inc
NGD
| $114K | ﹤0.01% |
150,000
-6,700
| -4% | -$5.42K |
|
4856
Dr. Reddy's Laboratories
RDY
$10.3B
| $114K | ﹤0.01% |
15,105
+11,585
| +329% | +$81.5K |
|
|
OIL
4857
DELISTED
iPath Pure Beta Crude Oil ETN
OIL
| $114K | ﹤0.01% |
+7,900
| New | +$140K |
|
|
AUTL
4858
Autolus Therapeutics
AUTL
$620M
| $113K | ﹤0.01% |
+3,461
| New | +$114K |
|
4859
PUT
Boston Properties
BXP
$10.8B
| $113K | ﹤0.01% |
1,000
-1,900
| -66% | -$230K |
|
4860
CALL
Direxion Daily Real Estate Bear 3X ETF
DRV
$27.1M
| $113K | ﹤0.01% |
206
+200
| +3,333% | +$98K |
|
4861
Intrepid Potash
IPI
$495M
| $113K | ﹤0.01% |
4,381
-10,173
| -70% | -$349K |
|
4862
Kimbell Royalty Partners
KRP
$1.51B
| $113K | ﹤0.01% |
+8,300
| New | +$147K |
|
|
MNTX
4863
DELISTED
Manitex International, Inc.
MNTX
| $113K | ﹤0.01% |
19,976
-7,488
| -27% | -$58.1K |
|
|
CCRN
4864
DELISTED
Cross Country Healthcare
CCRN
| $112K | ﹤0.01% |
15,213
-23,858
| -61% | -$200K |
|
|
KA
4865
DELISTED
Kineta, Inc. Common Stock
KA
| $112K | ﹤0.01% |
246
+131
| +114% | +$88.8K |
|
|
ATCO
4866
CALL
DELISTED
Atlas Corp.
ATCO
| $112K | ﹤0.01% |
14,300
-21,600
| -60% | -$188K |
|
|
CDR
4867
DELISTED
Cedar Realty Trust, Inc
CDR
| $112K | ﹤0.01% |
5,436
-24,133
| -82% | -$585K |
|
|
AGEN
4868
Agenus
AGEN
$320M
| $111K | ﹤0.01% |
2,369
-2,213
| -48% | -$92.3K |
|
4869
Ardmore Shipping
ASC
$659M
| $111K | ﹤0.01% |
23,604
-20,477
| -46% | -$128K |
|
|
HTT
4870
PUT
High Templar Tech Ltd
HTT
$388M
| $111K | ﹤0.01% |
25,800
-23,400
| -48% | -$112K |
|
4871
Tencent Music
TME
$13.8B
| $111K | ﹤0.01% |
+8,451
| New | +$108K |
|
4872
PUT
Valmont Industries
VMI
$9.58B
| $111K | ﹤0.01% |
1,000
-1,900
| -66% | -$237K |
|
4873
WillScot Mobile Mini Holdings
WSC
$4.12B
| $111K | ﹤0.01% |
11,754
-1,619
| -12% | -$22.9K |
|
|
FLXN
4874
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $111K | ﹤0.01% |
9,837
-3,412
| -26% | -$53.5K |
|
|
I
4875
PUT
DELISTED
INTELSAT S. A.
I
| $111K | ﹤0.01% |
+5,200
| New | +$141K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.